Table 3. Therapeutic protocol: medium–severe phase of COVID-19.
| Laser system parameters | |
|---|---|
| Wavelengths | Infrared laser (780–900 nm), or red laser (630–660 nm) |
| Average power | 50–100 mW |
| Dose | 6–10 J/cm2 |
| Area | 10 cm2 |
| Sessions | 3–10 once-daily sessions |
| Laser probes positions | |
| Intranasal: 1 minute/cm2 (100 mW) 2 minutes/cm2 (50 mW) |
Noncontact technique |
| Over right and left tonsils 1 minute/cm2 (100 mW) 2 minutes/cm2 (50 mW) |
Transcutaneous (place laser over the skin) |
| Over the trachea 1 minute/cm2 (100 mW) 2 minutes/cm2 (50 mW) |
Transcutaneous |
| Over the veins in the cubital areas 8 minute/cm2 (100 mW) 15 minutes/cm2 (50 mW) |
Transcutaneous blood laser therapy |
| Over the lungs 1:30–2 minute/cm2 (100 mW) 2–3 minutes/cm2 (50 mW) |
Bilaterally over apical, middle, and lower lobes, front and back of thorax; transcutaneous over the intercostal spaces |
| Over the bronchus 1:30–2 minute/cm2 (100 mW) 2–3 minutes/cm2 (50 mW) |
Upper mediastinal area: transcutaneous |